Treatment of pulmonary fibrosis in one convalescent patient with corona virus disease 2019 by oral traditional Chinese medicine decoction: A case report

J Integr Med. 2021 Mar;19(2):185-190. doi: 10.1016/j.joim.2020.11.005. Epub 2020 Dec 5.

Abstract

After one-month of oral treatment with traditional Chinese medicine decoction, without using other drugs, the lung inflammatory exudate, pulmonary fibrosis and quality of life of a 61-year-old female patient with corona virus disease 2019 (COVID-19) were significantly improved. No recurrence or deterioration of the patient's condition was found within seven weeks of treatment and follow-up, and no adverse events occurred, indicating that oral Chinese medicine decoction was able to improve the pulmonary inflammation and fibrosis in a patient recovering from COVID-19, but further research is still needed.

Keywords: Corona virus disease 2019; Exudation; Inflammation; Pulmonary fibrosis; Traditional Chinese medicine.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Oral
  • COVID-19 / complications*
  • COVID-19 / virology
  • Drugs, Chinese Herbal / therapeutic use*
  • Exudates and Transudates
  • Female
  • Humans
  • Inflammation / drug therapy
  • Inflammation / etiology
  • Lung / drug effects*
  • Lung / pathology
  • Magnoliopsida
  • Medicine, Chinese Traditional*
  • Middle Aged
  • Phytotherapy*
  • Pulmonary Fibrosis / drug therapy*
  • Pulmonary Fibrosis / etiology
  • SARS-CoV-2

Substances

  • Drugs, Chinese Herbal